118th Congress · HOUSE BILLENACTED

H.R. 1734Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023

To require coordinated National Institute of Standards and Technology science and research activities regarding illicit drugs containing xylazine, novel synthetic opioids, and other substances of concern, and for other purposes.

Science, technology, communications
Introduced Mar 23, 2023
Last action Dec 19, 2023
Pipeline · Bill → Law
Step 1
Introduced
Mar 23, 2023
Step 2
Referred
Mar 23, 2023
Science
Step 3
Committee
Mar 29, 2023
Reported out
Step 4
House floor
Step 5
Senate
Jun 22, 2023
Passed Senate w/ Changes
Step 6
Resolve Changes
House Must Approve Changes
Step 7
Signed
Dec 19, 2023
SummaryCRS Summary

This bill requires the National Institute of Standards and Technology (NIST) to support research and other activities related to identifying xylazine (a compound used in veterinary medicine as a nonopioid tranquilizer), novel synthetic opioids, and other new psychoactive substances. In particular, NIST must support basic measurement science and research; near-real time spectrometry capabilities (i.e., a technique for rapidly identifying the chemical composition of a substance); strategies and voluntary best practices for handling, transporting, and analyzing such substances; and collaboration with other government agencies, institutions of higher education, and the private sector to enhan...

Provisions · 3 sectionsEnrolled
Similar Bills · 1 matches
BillText overlapStatus
S. 1280TRANQ Research Act of 2023
73%
INCORPORATED
Roll Call Votes · 1
Timeline · 24 actions
Dec 19, 2023
Signed by President.
Dec 19, 2023
Became Public Law No: 118-23.
Dec 14, 2023
Presented to President.
Dec 4, 2023
Mr. Lucas moved that the House suspend the rules and agree to the Senate amendment.
Dec 4, 2023
DEBATE - The House proceeded with forty minutes of debate on the motion to suspend the rules and agree to the Senate amendment to H.R. 1734.
Dec 4, 2023
On motion that the House suspend the rules and agree to the Senate amendment Agreed to by voice vote.
Dec 4, 2023
Motion to reconsider laid on the table Agreed to without objection.
Jun 26, 2023
Message on Senate action sent to the House.
Jun 22, 2023
Measure laid before Senate by unanimous consent.
Jun 22, 2023
Passed Senate with an amendment by Unanimous Consent.
May 15, 2023
Received in the Senate, read twice.
May 11, 2023
Considered as unfinished business.
May 11, 2023
On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 425 - 0 (Roll no. 212).ROLL CALLpass
May 11, 2023
Motion to reconsider laid on the table Agreed to without objection.
May 9, 2023
Mr. Miller (OH) moved to suspend the rules and pass the bill, as amended.
May 9, 2023
Considered under suspension of the rules.
May 9, 2023
DEBATE - The House proceeded with forty minutes of debate on H.R. 1734.
May 9, 2023
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
May 5, 2023
Reported (Amended) by the Committee on Science, Space, and Technology. H. Rept. 118-50.
May 5, 2023
Placed on the Union Calendar, Calendar No. 34.
Mar 29, 2023
Committee Consideration and Mark-up Session Held.
Mar 29, 2023
Ordered to be Reported (Amended) by the Yeas and Nays: 36 - 0.
Mar 23, 2023
Introduced in House
Mar 23, 2023
Referred to the House Committee on Science, Space, and Technology.